Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...

Has it ever happened that your 'cooler' sibling stole all your limelight? Well, that's exactly what retinal is doing to ...

If you’ve spent any time doom-scrolling through skincare trends lately, you’ve likely noticed a new character entering the ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.

Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...

After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

RetinalGenix is developing a portfolio of non‑invasive imaging solutions, including a portable Retinal Imaging Screening Device and the RetinalCam remote monitoring system, designed for use without ...

About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...